|Mr. Walter Oberhansli||Founder & Chairman||1.06M||N/A||1958|
|Mr. Walter Hess||CEO & Member of Exec. Board||N/A||N/A||1965|
|Mr. Marcel Ziwica||CFO & Member of Exec. Board||N/A||N/A||1975|
|Mr. Bernd Gschaider||COO & Member of Exec. Board||N/A||N/A||1966|
|Mr. David Maso||Head of Europe & Member of Exec. Board||N/A||N/A||1971|
|Mr. Emanuel Lorini||Head of Switzerland & Member of the Exec. Board||N/A||N/A||1977|
|Mr. Madhu Nutakki||CTO & Member of Exec. Board||N/A||N/A||1971|
|Christoph Herrmann||Head of Investor Relations||N/A||N/A||N/A|
|Lisa Luthi||Head of Corp. Communications||N/A||N/A||N/A|
Zur Rose Group AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers consumer health, beauty, and personal care products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. The company was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
Zur Rose Group AG’s ISS Governance QualityScore as of December 1, 2022 is 5. The pillar scores are Audit: 8; Board: 7; Shareholder Rights: 1; Compensation: 4.